These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34032027)
1. Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host. Peng Z; Wu J; Wang K; Li X; Sun P; Zhang L; Huang J; Liu Y; Hua X; Yu Y; Pan C; Wang H; Zhu L Adv Sci (Weinh); 2021 Jul; 8(14):e2100549. PubMed ID: 34032027 [TBL] [Abstract][Full Text] [Related]
2. A promising bioconjugate vaccine against hypervirulent Feldman MF; Mayer Bridwell AE; Scott NE; Vinogradov E; McKee SR; Chavez SM; Twentyman J; Stallings CL; Rosen DA; Harding CM Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18655-18663. PubMed ID: 31455739 [TBL] [Abstract][Full Text] [Related]
3. Identification and Evaluation of Recombinant Outer Membrane Proteins as Vaccine Candidates Against Zhang BZ; Hu D; Dou Y; Xiong L; Wang X; Hu J; Xing SZ; Li W; Cai JP; Jin M; Zhang M; Lin Q; Li M; Yuen KY; Huang JD Front Immunol; 2021; 12():730116. PubMed ID: 34745099 [No Abstract] [Full Text] [Related]
4. Co-immunization with DNA vaccines encoding yidR and IL-17 augments host immune response against Lv Z; Zhang X; Zhao K; Du L; Wang X; Chu Y; Huang T Virulence; 2024 Dec; 15(1):2345019. PubMed ID: 38656137 [No Abstract] [Full Text] [Related]
5. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats. Chhibber S; Rani M; Vanashree Y Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064 [TBL] [Abstract][Full Text] [Related]
6. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model. Hussein KE; Bahey-El-Din M; Sheweita SA Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae. Lundberg U; Senn BM; Schüler W; Meinke A; Hanner M Hum Vaccin Immunother; 2013 Mar; 9(3):497-505. PubMed ID: 23250007 [TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice. Kurupati P; Ramachandran NP; Poh CL Clin Vaccine Immunol; 2011 Jan; 18(1):82-8. PubMed ID: 21048001 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. Hsieh PF; Lin TL; Yang FL; Wu MC; Pan YJ; Wu SH; Wang JT PLoS One; 2012; 7(3):e33155. PubMed ID: 22427976 [TBL] [Abstract][Full Text] [Related]
11. Efficient Production of Self-Assembled Bioconjugate Nanovaccines against Zhang Y; Sun P; Li T; Li J; Ye J; Li X; Wu J; Lu Y; Zhu L; Wang H; Pan C Nanomaterials (Basel); 2024 Apr; 14(8):. PubMed ID: 38668222 [TBL] [Abstract][Full Text] [Related]
12. [Biosynthesis of polysaccharide conjugate vaccines against Klebsiella pneumoniae serotype O2 strains]. Zhang L; Pan C; Feng E; Hua X; Yu Y; Wang H; Zhu L Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1899-1907. PubMed ID: 33164465 [TBL] [Abstract][Full Text] [Related]
13. Results of passive and active immunization directed against ferric aerobactin in experimental enterobacterial infections in mice and chickens. Le Roy D; Crouzier C; Dho-Moulin M; Dumont AS; Bouchet A; Lafont JP; Andremont A Res Microbiol; 1995 Feb; 146(2):167-74. PubMed ID: 7652210 [TBL] [Abstract][Full Text] [Related]
14. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. Hegerle N; Choi M; Sinclair J; Amin MN; Ollivault-Shiflett M; Curtis B; Laufer RS; Shridhar S; Brammer J; Toapanta FR; Holder IA; Pasetti MF; Lees A; Tennant SM; Cross AS; Simon R PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914 [TBL] [Abstract][Full Text] [Related]
16. Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli. Liu Y; Pan C; Wang K; Guo Y; Sun Y; Li X; Sun P; Wu J; Wang H; Zhu L Microb Cell Fact; 2023 May; 22(1):95. PubMed ID: 37149632 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma. Campbell WN; Hendrix E; Cryz S; Cross AS Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151 [TBL] [Abstract][Full Text] [Related]
19. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections. Lipworth S; Vihta KD; Chau KK; Kavanagh J; Davies T; George S; Barker L; Vaughan A; Andersson M; Jeffery K; Oakley S; Morgan M; Peto TEA; Crook DW; Walker AS; Stoesser N Clin Infect Dis; 2021 Dec; 73(12):2276-2282. PubMed ID: 33411882 [TBL] [Abstract][Full Text] [Related]
20. Progress towards the development of Klebsiella vaccines. Choi M; Tennant SM; Simon R; Cross AS Expert Rev Vaccines; 2019 Jul; 18(7):681-691. PubMed ID: 31250679 [No Abstract] [Full Text] [Related] [Next] [New Search]